FDA Coronavirus (COVID-19) Update: April 17th, 2020
April 17, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA provided an update on one potential treatment called convalescent plasma and is encouraging those who have recovered from COVID-19 Coronavirus to donate plasma to help others fight this disease. Convalescent plasma is an antibody-rich product made from blood donated by people who have recovered from the disease caused by the virus.
Coronavirus
